TrialPal
ePRO & eCOA

TrialPal is our eCOA (electronic Clinical Outcome Assessment), ePRO (electronic Patient Reported Outcomes) and Site Mobile and web application used in vaccine clinical trials and decentralized clinical trials.

Banner TrialPal
Banner TrialPal

TrialPal
ePRO & eCOA

TrialPal is our eCOA (electronic Clinical Outcome Assessment), ePRO (electronic Patient Reported Outcomes) and Site Mobile and web application used in vaccine clinical trials and decentralized clinical trials.

TrialPal
Suite

Setup Study Protocols in minutes and prepare Screenshots for IRB Submission in a Day.

Subject’s easy-to-report, friendly Web, PWA, and Mobile App with offline functionality.

The Site’s management console, with reports, eDiary view, eDiary Assessment, and subject follow-up.

Interactive Multimedia eConsent enriched with AI.

The participant's best friend

TrialPal is an intuitive and easy-to-use tool that monitors clinical trial participants and the study, through dashboards combined with a user-friendly interface created to generate data directly from the trial participants

Fully Compliant

GCP
FDA
GDPR
EU ANNEX
HIPAA
ALCOA

Dashboards for
Decision-Making

Study
Dashboard

Our TrialPal dashboards provide an overview of the trial status. This is accomplished with on-demand indicators such as; symptomatology, intensity per participant by group or site, as well as reports and visit completion.

Click to see full image

e-Diary
Dashboard

The dashboards allow detailed tracking of AE and SAE, and other key variables to make data-driven decisions throughout the study. The practical design makes it easier to do analytics and presentations.

Click to see full image

TrialPal Mobile

TrialPal
Features

Create any eDiary and any other trial-specific forms in as little as 1-2 hours as per protocol specifications.

Dual data entry options for participants.
Customize notifications to participants by study and user.

With our conciliation module you can review and conciliate easily all the symptoms reported.

This allows users to activate additional modules such as Chat, eConsent, and Telehealth (Beta version), it also provides a way to enable hybrid or Decentralized Clinical Trials (DCT) when integrating TrialPal with Trial360 and EDC.

To enhance interoperability between site CTMS, EDCs, or any third-party application.

Reduce implementation and operational costs.

In TrialPal you can made forms for your surveillance reports using a design mode; with drag-and-drop features, and all the functionalities you need to create the perfect form for your study needs.

TrialPal App works in offline mode. The App saves the report on the device, and once it is back online, all the pending data is sent automatically.

 

Besides, with the traveler mode, you can go anywhere worldwide and keep reporting the days you are out of your time zone.

Easily set up vaccine clinical trial eDiary or surveillance forms for symptom monitoring, including: subforms, grading, alerts, and AEs – SAEs real-time notifications to stakeholders, where sites can also act quickly upon receiving subject reports.

 

With the Trial Site App, physicians can manage reconciliations, and with Trial API, data is sent automatically to the eCRF or EDC system.

Key
Aspects

Reliable

Configurable

Real-time information

User-friendly

Traceability

Works in Mobile and Web devices

Success
Stories

We studied the performance of a smartphone application-based participatory syndromic surveillance (PSS) system for collecting syndromic data (acute febrile illness [AFI] and acute gastroenteritis [AGE]) to detect dengue virus (DENV) and norovirus (NoV) on a cohort of children living in a low-resource and rural area of Guatemala.

 

  • 469 Participants
  • 207 Households
  • 322 Participants >68% response rate during the study (April 2015 – June 2016)

Read the article Performance of a Smartphone Application-Based Participatory Syndromic Surveillance System for Acute Febrile Illness and Acute Gastroenteritis in Rural Guatemala by D. Olson, Takeda Pharmaceuticals: Consultant, Grant recipient. R. Zambrano, Integra IT: Employee and Shareholder, Salary. S. Rodriguez-Castro, Integra IT: Employee and Shareholder, Salary. E. J. Asturias, Takeda Pharmaceuticals: Consultant and Grant Investigator, Grant recipient, at Oxford Academic.

Fe vs Blood sample collection

FE known by site vs Blood sample collection

  • 77% of samples were collected in the first 2 days.
  • 88% of samples were collected in the window.

Clinical Trial: 935 subjects
Phase 2 Dengue Vaccine
Site: Cevaxin Panama

Schedule a Demo

Interested in our TrialPal Solution? Want to know more about our TrialPal Pricing? Contact us for a customized quote!

Schedule a meeting with us!

TrialPal and PFS
error: Content is protected !!